Compounds > cyanine green g base
Page last updated: 2024-12-06

cyanine green g base

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID31416
SCHEMBL ID35556
MeSH IDM0110551

Synonyms (108)

Synonym
1,4-bis(p-tolylamino)anthraquinone
d & c green no. 6
anthraquinone, 1,4-di-p-toluidino-
micro-lex green 5b
zelen rozpoustedlova 3 [czech]
9,10-anthracenedione, 1,4-bis((4-methylphenyl)amino)-
ci 61565
1,4-bis((4-methylphenyl)amino)-9,10-anthracenedione
nsc 84207
einecs 204-909-5
anthraquinone, 1,4-bis(p-tolylamino)-
bis-1,4-p-tolylaminoanthrchinon [czech]
zelen sudan 4b [czech]
anthcoquinone cyanine green base
brn 2227927
1,4-bis[(4-methylphenyl)amino]anthra-9,10-quinone
1,4-bis(4-methylanilino)anthracene-9,10-dione
9,10-anthracenedione, 1,4-bis[(4-methylphenyl)amino]-
128-80-3
alizarine cyanine green base
fat soluble green anthraquinone
ahcoquinone cyanine green base
1,4-di-p-toluidinoanthraquinone
anthraquinone,4-bis(p-tolylamino)-
fat soluble anthraquinone green
quinazarin green
1,4-bis(p-tolylamine)anthraquinone
sudan green 4b
green no. 202
1,4-di-(4'-toluidino)anthraquinone
9, 1,4-bis[(4-methylphenyl)amino]-
fat-soluble anthraquinone green
nsc84207
alizarine green g base
arlosol green b
nitro fast green gb
waxoline green
wln: l c666 bv ivj dmr d1 & gmr d1
d and c green no. 6
cyanine green g base
quinizarine green base
d&c green 6
amaplast green oz
solvent green 3
bis-1,4-p-tolylaminoanthrchinon
arlosol green bs
macro-lex green 5b
1,4-bis(p-toluidino)anthraquinone
c-green 10
c.i. solvent green 3
nsc-84207
waxoline green g
arlosol green bss
anthraquinone green g base
organol fast green j
organol green j
quinizarin green ss
11091 green
c.i. 61565
solvent green 3, dye content 95 %
Q0021
AKOS001712259
1,4-bis[(4-methylphenyl)amino]anthracene-9,10-dione
STK731664
d&c green #6
d&c green no. 6
zelen rozpoustedlova 3
hsdb 8006
c.i. disperse green 6:1
solvaperm green gsb
zelen sudan 4b
d.c. green no. 6
1,4-di-4-toluidinoanthraquinone
ec 204-909-5
1,4-di(4'-toluidino)anthraquinone
4qp5u84yf7 ,
unii-4qp5u84yf7
FT-0606905
1,4-bis(p-tolylamino)anthracene-9,10-dione
ci 61565 [inci]
midori202 [inci]
green 6
midori202
green 6 [inci]
d & c green #6 [vandf]
d&c green dye no 6
solvent green 3 [inci]
dc green no. 6
quinizarin green ss [mi]
f d & c green #6 [vandf]
SCHEMBL35556
DTXSID9044376
1,4-di(4-toluidino)anthra-9,10-quinone #
anthraquinone, 1,4-bis(4'-toluidino)-
d&c green no 6
waxoline green 6gfw
anthraquinone, 1,4-(4,4'-ditoluidino)-
mfcd00001195
1,4-bis[(4-methylphenyl)amino]-9,10-dihydroanthracene-9,10-dione
J-005628
solvent green 3, analytical standard
solventgreen3
Q7272243
c.i.solvent green 3
H11260
14-bis(p-tolylamino)anthracene-910-dione
A888969
CS-0064470

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In summary, neither test material appeared to be highly toxic following inhalation."( The inhalation toxicity of two commercial dyes: solvent yellow 33 and solvent green 3.
Banas, DA; Cheng, YS; Dutcher, JS; Hahn, FF; Henderson, RF; Marshall, TC; Mauderly, JL; Pickrell, JA; Seiler, FA; Sun, JD, 1987)		0.27
" In the same species several other adverse findings were noted: these included adenocarcinomas of the breast in the high-dose group and a dose-related incidence of biliary hyperplasia."( Inhalation toxicity of a smoke containing Solvent Yellow 33, Disperse Red 9 and Solvent Green 3 in laboratory animals.
Brown, RF; Colgrave, HF; Gazzard, M; Marrs, TC, 1984)		0.27

Bioavailability

ExcerptReferenceRelevance
"In order to enhance the dissolution profile and oral bioavailability of megestrol acetate (MA), solid dispersions of MA (MASDs) were formulated with copovidone and crystal sugar as a hydrophilic polymeric carrier and an inert core bead, respectively."( Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability.
Choi, SU; Choi, YW; Hong, SW; Jeon, HR; Kang, MH; Lee, BS; Lee, J; Moon, KY; Park, SH; Park, SJ; Song, WH, 2011)		0.37

Dosage Studied

ExcerptRelevanceReference
" Absorption of the dosage formulation should be paid attention when poorly water-soluble drugs are orally administered with lipid-based formulation."( Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs.
Iwanaga, K; Kakemi, M; Kushibiki, T; Miyazaki, M, 2006)		0.33
" We conclude that MASD (1:1) is a good candidate for the development of oral solid dosage forms."( Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability.
Choi, SU; Choi, YW; Hong, SW; Jeon, HR; Kang, MH; Lee, BS; Lee, J; Moon, KY; Park, SH; Park, SJ; Song, WH, 2011)		0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (55.56)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.61 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
1-anilino-8-naphthalenesulfonate
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd. 8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.		2.0310aminonaphthalene;
naphthalenesulfonic acid		fluorescent probe
sucrose
Saccharum: A plant genus of the family POACEAE widely cultivated in the tropics for the sweet cane that is processed into sugar.		2.0610glycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
colchicine
(S)-colchicine : A colchicine that has (S)-configuration. It is a secondary metabolite, has anti-inflammatory properties and is used to treat gout, crystal-induced joint inflammation, familial Mediterranean fever, and many other conditions.		2.0310alkaloid;
colchicine		anti-inflammatory agent;
gout suppressant;
mutagen
isoprene
isoprene: used in manufacture of ''synthetic'' rubber, butyl rubber; copolymer in production of elastomers; structure. isoprene : A hemiterpene with the formula CH2=C(CH3)CH=CH2; the monomer of natural rubber and a common structure motif to the isoprenoids, a large class of other naturally occurring compounds.		2.0210alkadiene;
hemiterpene;
volatile organic compound		plant metabolite
disperse red 9
[no description available]		1.9610
megestrol acetate
[no description available]		2.061020-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester		antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
ConditionIndicatedRelationship StrengthStudiesTrials